While the biopharmaceutical industry as a whole has had some limited success, attempts to employ GE plants as a production platform for “plant-made pharmaceuticals” have foundered despite 15 years’ of field trials and huge infusions of capital. […]
|
||||||
|
CBD moratorium on Terminator Technology reaffirmed, but with qualifications Granada, 28 January 2006 (Third World Network) – The fourth meeting of the Ad Hoc Open-ended Intersessional Working Group on Article 8(j) and related provisions of the […] Item 1 Renewed calls to ban Terminator Technology as CBD meets Kuala Lumpur, 23 January (Lim Li Ching) – As governments gather for the fourth meeting of the Ad Hoc Open-ended Intersessional Working Group on Article 8(j) and related pr […] Item 1 A New Wariness as the Risks Shift in Biotech Investing December 30, 2005 New York Times A New Wariness as the Risks Shift in Biotech Investing By ANDREW POLLACK WHEN it comes to biotechnology start-ups, venture ca […] WHO BENEFITS FROM GM CROPS? MONSANTO AND ITS CORPORATE DRIVEN GENETICALLY MODIFIED CROP REVOLUTION. KEY FACTS By Friends of the Earth International, January 2006 […] This study announces the results of a three-year study (2002-2005) of the impact of bollworm resistant Bt cotton in Andhra Pradesh in India. The results of the survey revealed that Monsanto hybrids were utter failure compared to the Non-Bt hybrids. […] Fr Sean McDonagh of the Columban Missionary writes on the ethical and moral aspects of genetic engineering. He is critical of the corporate powers which continue to push GM food despite evidence that such food could have health impacts. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||